Alkermes (ALKS) Non Operating Income (2010 - 2026)
Alkermes' Non Operating Income came in at -$20.23 million for Q2 2026, compared with $11.86 million a year earlier.
Powered by 
Analysis
Alkermes (ALKS) Non Operating Income (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Alkermes reported Non Operating Income of -$19.94 million; for FY2025, it came in at $37.49 million, up 62.2% from FY2024.
- Non Operating Income carries a five-year compound annual growth rate of 18.7% (FY2020 to FY2025).
- Going back by year, Non Operating Income was $23.11 million in FY2024 (+212.5%), $7.4 million in FY2023, -$25.04 million in FY2022 and -$10.02 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Non Operating Income since Q1 2019.
- Year-over-year, Non Operating Income increased in five of the last six quarters, with growth averaging 82.3%.
- The fastest year-over-year change in Non Operating Income over five years came in Q1 2025 (growth of 224.6%), and the weakest in Q4 2025 (a decline of 68.4%).
- Business Quant data shows ALKS's Non Operating Income at -$13.65 million (Q1 2026), $2.27 million (Q4 2025) and $11.66 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Alkermes | 6.73 Bn | 3.86 Bn | 397.90 Mn | -20.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -20.23 Mn |
| Mar 31, 2026 | -13.65 Mn |
| Dec 31, 2025 | 2.27 Mn |
| Sep 30, 2025 | 11.66 Mn |
| Jun 30, 2025 | 11.86 Mn |
| Mar 31, 2025 | 11.70 Mn |
| Dec 31, 2024 | 7.20 Mn |
| Sep 30, 2024 | 5.47 Mn |
| Jun 30, 2024 | 6.84 Mn |
| Mar 31, 2024 | 3.60 Mn |
| Dec 31, 2023 | 3.69 Mn |
| Sep 30, 2023 | 3.51 Mn |
| Jun 30, 2023 | 560,000.00 |
| Mar 31, 2023 | -361,000.00 |
| Dec 31, 2022 | -1.11 Mn |
| Sep 30, 2022 | -6.73 Mn |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | -18.41 Mn |
| Dec 31, 2021 | -2.16 Mn |
| Sep 30, 2021 | -6.88 Mn |
API Access
Alkermes Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();